Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2008Company announces management changes and further organizational consolidation
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the...
-
May 29, 2008Environmentally focused improvements are hallmark of renovations to Endosurgery headquarters
Boston Scientific Corporation (NYSE: BSX) today announced it has received Leadership in Energy and Environmental Design (LEED) certification from...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced that Boston Scientific has completed its...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
May 20, 2008Positive results presented at Digestive Disease Week® 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an international, multi-center patient registry documenting...
-
May 19, 2008New size allows for treatment of smaller-diameter diseased saphenous vein grafts
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its FilterWire EZ™ Embolic Protection System in a new 2.25 - 3.5 mm size,...
-
May 16, 2008ACUITY® Spiral lead has smallest left ventricular lead tip profile in the industry
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY® Spiral left ventricular...
-
May 16, 2008Results of international, multi-center registry presented at conference
Boston Scientific Corporation (NYSE: BSX) today announced that results from an international, multi-center patient registry documenting the safety...
-
May 15, 2008ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy
Boston Scientific Corporation (NYSE: BSX) today announced a new clinical science initiative, ALTITUDE, which will analyze data(1) from the...
-
May 13, 2008COGNIS™ CRT-D and TELIGEN™ ICD represent entirely new platforms
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS™ cardiac...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed two-year results from the SPIRIT III clinical trial, which continue to...
-
May 13, 2008Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
Boston Scientific Corporation (NYSE: BSX) and the International Diabetes Federation (IDF) today announced that Boston...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA™ family of pacemakers....
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its...
-
Apr 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 5-7 in...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) today announced completion of enrollment in the Multicenter Automatic Defibrillator Implantation Trial...
-
Apr 23, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards...
-
Apr 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2008, as well as guidance for...
-
Apr 17, 2008Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval for the sale of its TAXUS® Liberte® paclitaxel-eluting...
-
Apr 16, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced the signing of a definitive...
-
Apr 15, 2008Emerging technology will potentially enable access to MRI exams for implantable cardiac device patients
Boston Scientific Corporation (NYSE: BSX) and Surgi-Vision, Inc., a privately held company, today announced a licensing and...
-
Apr 14, 2008ACUITY® Steerable lead also receives reimbursement approval; Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced Japanese Ministry of Health, Labor and Welfare (MHLW) approval of its ACUITY® Steerable...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31,...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Timothy Pratt as its new General Counsel. Pratt is a nationally...
-
Apr 2, 2008Judgment entered in favor of Guidant and its former directors/officers
Boston Scientific Corporation (NYSE: BSX) today announced that United States District Judge Sarah Evans Barker, Indianapolis, dismissed...
-
Apr 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled analysis of patients from its TAXUS IV and TAXUS...
-
Apr 1, 2008Results from TAXUS IV and V randomized clinical trials favor DES compared to bare-metal stents
Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V...
-
Mar 31, 2008At two years, Company's TAXUS® and PROMUS™ Stents demonstrate positive and similar outcomes
Boston Scientific Corporation (NYSE: BSX) today welcomed positive two-year results from Abbott's prospective, randomized (3:1), single...
-
Mar 31, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of two-year data from more than 7,000 patients in...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 4,772 patients from its TAXUS ARRIVE 1 and 2...
-
Mar 25, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for...
-
Mar 11, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 18...
-
Mar 3, 2008ACUITY® Spiral lead offers flexibility for placement in small, medium and large veins
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac...
-
Feb 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the first European implants of its COGNIS™ cardiac resynchronization therapy...
-
Feb 26, 2008Dr. Jay Schnitzer to join the Company
Boston Scientific Corporation (NYSE: BSX) today announced that Jay J. Schnitzer, M.D., Ph.D. will be joining the Company's Clinical Sciences...
-
Feb 25, 2008Approvals include CONFIENT™ ICD, LIVIAN™ CRT-D and upgraded LATITUDE® Patient Management System
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm...
-
Feb 14, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Fluid Management and Venous Access businesses to...
-
Feb 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
Feb 11, 2008PROENCY will provide real-world clinical data on the PROMUS™ Stent
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in its PROENCY (PROMUS™, ENdeavor® and...
-
Feb 4, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2007, as well as...
-
Feb 4, 2008'Close the Gap' brings together advocates from cardiologists to coaches
Boston Scientific Corporation (NYSE: BSX) today announced the public debut of an educational initiative called "Close the Gap," which is aimed at...
-
Jan 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...
-
Jan 23, 2008
Boston Scientific (NYSE: BSX) today issued the following statement from Donald S. Baim, M.D., Chief Medical and Scientific Officer, on an article in the New...
-
Jan 23, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 22, 2008
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its COGNIS™ cardiac resynchronization therapy defibrillator...